Evidence map›Paper›PMID 25901220›Full record

ArticleWorld journal of gastrointestinal endoscopy2015

Re-bleeding events in patients with obscure gastrointestinal bleeding after negative capsule endoscopy.

Pedro Magalhães-Costa, Miguel Bispo, Sofia Santos, Gilberto Couto, Leopoldo Matos, Cristina Chagas

Abstract read
In one paragraph

Article in World journal of gastrointestinal endoscopy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Observational
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Capsule endoscopy in Portugal.Annals of translational medicine · 2017
    Article
  11. Review
  12. What is the impact of capsule endoscopy in the long term period?World journal of gastrointestinal endoscopy · 2016
    Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pedro Magalhães-CostaPedro Magalhães-Costa, Miguel Bispo, Sofia Santos, Gilberto Couto, Leopoldo Matos, Cristina Chagas, Gastroenterology Department, Hospital Egas Moniz, Centro Hospitalar Lisboa Ocidental, 1349-019 Lisboa, Portugal.
Miguel BispoPedro Magalhães-Costa, Miguel Bispo, Sofia Santos, Gilberto Couto, Leopoldo Matos, Cristina Chagas, Gastroenterology Department, Hospital Egas Moniz, Centro Hospitalar Lisboa Ocidental, 1349-019 Lisboa, Portugal.
Sofia SantosPedro Magalhães-Costa, Miguel Bispo, Sofia Santos, Gilberto Couto, Leopoldo Matos, Cristina Chagas, Gastroenterology Department, Hospital Egas Moniz, Centro Hospitalar Lisboa Ocidental, 1349-019 Lisboa, Portugal.
Gilberto CoutoPedro Magalhães-Costa, Miguel Bispo, Sofia Santos, Gilberto Couto, Leopoldo Matos, Cristina Chagas, Gastroenterology Department, Hospital Egas Moniz, Centro Hospitalar Lisboa Ocidental, 1349-019 Lisboa, Portugal.
Leopoldo MatosPedro Magalhães-Costa, Miguel Bispo, Sofia Santos, Gilberto Couto, Leopoldo Matos, Cristina Chagas, Gastroenterology Department, Hospital Egas Moniz, Centro Hospitalar Lisboa Ocidental, 1349-019 Lisboa, Portugal.
Cristina ChagasPedro Magalhães-Costa, Miguel Bispo, Sofia Santos, Gilberto Couto, Leopoldo Matos, Cristina Chagas, Gastroenterology Department, Hospital Egas Moniz, Centro Hospitalar Lisboa Ocidental, 1349-019 Lisboa, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate long-term re-bleeding events after a negative capsule endoscopy in patients with obscure gastrointestinal bleeding (OGIB) and the risk factors associated with the procedure.

methodsPatients referred to Hospital Egas Moniz (Lisboa, Portugal) between January 2006 and October 2012 with OGIB and a negative capsule endoscopy were retrospectively analyzed. The following study variables were included: demographic data, comorbidities, bleeding-related drug use, hemoglobin level, indication for capsule endoscopy, post procedure details, work-up and follow-up. Re-bleeding rates and associated factors were assessed using a Cox proportional hazard analysis. The Kaplan-Meier method was used to estimate the cumulative incidence of re-bleeding at 1, 3 and 5 years, and the differences between factors were evaluated.

resultsThe study population consisted of 640 patients referred for OGIB investigation. Wireless capsule endoscopy was deemed negative in 113 patients (17.7%). A total of 64.6% of the population was female, and the median age was 69 years. The median follow-up was forty-eight months (interquartile range 24-60). Re-bleeding occurred in 27.4% of the cases. The median time to re-bleeding was fifteen months (interquartile range 2-33). In 22.6% (n = 7) of the population, small-bowel angiodysplasia was identified as the culprit lesion. A univariate analysis showed that age > 65 years old, chronic kidney disease, aortic stenosis, anticoagulant use and overt OGIB were risk factors for re-bleeding; however, on a multivariate analysis, there were no risk factors for re-bleeding. The cumulative risk of re-bleeding at 1, 3 and 5 years of follow-up was 12.9%, 25.6% and 31.5%, respectively. Patients who presented with overt OGIB tended to re-bleed sooner (median time for re-bleeding: 8.5 mo vs 22 mo).

conclusionPatients with OGIB despite a negative capsule endoscopy have a significant re-bleeding risk; therefore, these patients require an extended follow-up strategy.

Indexed as

AnemiaAngiodysplasiaCapsule endoscopyGastrointestinal hemorrhageRisk factors

Identifiers

PMID25901220
PMCPMC4400630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.